Luecht U, Scholz W, Geiben A, Haen E, Hempel G
Pharmaceutics. 2025; 17(2).
PMID: 40006546
PMC: 11858960.
DOI: 10.3390/pharmaceutics17020179.
Abduljalil K, De Sousa Mendes M, Salem F, Benaboud S, Gardner I
AAPS J. 2025; 27(1):43.
PMID: 39939515
DOI: 10.1208/s12248-025-01031-y.
Ozbey A, Meneses-Lorente G, Simmons B, McCallum S, Annaert P, Parrott N
Clin Pharmacokinet. 2025; .
PMID: 39934586
DOI: 10.1007/s40262-024-01468-y.
Rahim N, Sarfraz M, Bello A, Naqvi S
AAPS PharmSciTech. 2025; 26(1):38.
PMID: 39821536
DOI: 10.1208/s12249-024-03026-y.
Coates S, Bardhi K, Prasad B, Lazarus P
Pharmaceutics. 2025; 16(12.
PMID: 39771577
PMC: 11678041.
DOI: 10.3390/pharmaceutics16121599.
Inhibition of Neural Crest Cell Migration by Strobilurin Fungicides and Other Mitochondrial Toxicants.
Magel V, Blum J, Dolde X, Leisner H, Grillberger K, Khalidi H
Cells. 2025; 13(24.
PMID: 39768149
PMC: 11674305.
DOI: 10.3390/cells13242057.
In Vitro Hepatic Metabolism Input Parameters Support Toxicokinetic Simulations for the Formation of Methoxy Propionic Acid From β-Isomer Propylene Glycol Methyl Ether.
Werner S, Hegg L, Hopf N, Borgatta M, Suter-Dick L
Pharmacol Res Perspect. 2024; 12(6):e70037.
PMID: 39655648
PMC: 11629119.
DOI: 10.1002/prp2.70037.
Evaluation of Drug-Drug Interactions Between Clarithromycin and Direct Oral Anticoagulants Using Physiologically Based Pharmacokinetic Models.
Yang Z, Qu Y, Sun Y, Pan J, Zhou T, Yu Y
Pharmaceutics. 2024; 16(11).
PMID: 39598572
PMC: 11597346.
DOI: 10.3390/pharmaceutics16111449.
Clinical and Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib Drug-Drug Interactions.
Cilliers C, Howgate E, Jones H, Rahbaek L, Tran J
Clin Pharmacol Ther. 2024; 117(3):732-741.
PMID: 39587812
PMC: 11835422.
DOI: 10.1002/cpt.3506.
Predicting Food-Drug Interactions between Piperine and CYP3A4 Substrate Drugs Using PBPK Modeling.
Lin F, Hu Y, Zhang Y, Zhao L, Zhong D, Liu J
Int J Mol Sci. 2024; 25(20).
PMID: 39456737
PMC: 11506926.
DOI: 10.3390/ijms252010955.
Physiologically based pharmacokinetic modeling of long-acting extended-release naltrexone in pregnant women with opioid use disorder.
Shenkoya B, Gopalakrishnan M, Eke A
CPT Pharmacometrics Syst Pharmacol. 2024; 13(11):1939-1952.
PMID: 39380562
PMC: 11578127.
DOI: 10.1002/psp4.13252.
Development of a Generic Physiologically Based Kinetic Model for the Prediction of Internal Exposure to Organophosphate Pesticides.
Moerenhout T, Chen J, Bouwmeester H, Rietjens I, Kramer N
Environ Sci Technol. 2024; 58(42):18834-18845.
PMID: 39374537
PMC: 11500413.
DOI: 10.1021/acs.est.4c06534.
Use of physiologically based kinetic modeling to predict neurotoxicity and genotoxicity of methylglyoxal in humans.
Zheng L, Li X, Widjaja F, Liu C, Rietjens I
NPJ Sci Food. 2024; 8(1):79.
PMID: 39368970
PMC: 11455947.
DOI: 10.1038/s41538-024-00322-6.
Physiologically based pharmacokinetic modelling to predict potential drug-drug interactions of dersimelagon (MT-7117).
Ogasawara A, Kojima K, Murata Y, Shimizu H
Br J Clin Pharmacol. 2024; 91(2):451-463.
PMID: 39367654
PMC: 11773107.
DOI: 10.1111/bcp.16271.
Subcellular Drug Distribution: Exploring Organelle-Specific Characteristics for Enhanced Therapeutic Efficacy.
Liu X, Li M, Woo S
Pharmaceutics. 2024; 16(9).
PMID: 39339204
PMC: 11434838.
DOI: 10.3390/pharmaceutics16091167.
Application of Physiologically Based Pharmacokinetic Model to Delineate the Impact of Aging and Renal Impairment on Ceftazidime Clearance.
Abduljalil K, Gardner I, Jamei M
Antibiotics (Basel). 2024; 13(9).
PMID: 39335035
PMC: 11429240.
DOI: 10.3390/antibiotics13090862.
Whole Body Physiologically Based Pharmacokinetic Model to Explain A Patient With Drug-Drug Interaction Between Voriconazole and Flucloxacillin.
Abdullah-Koolmees H, van den Nieuwendijk J, Hoope S, De Leeuw D, Franken L, Said M
Eur J Drug Metab Pharmacokinet. 2024; 49(6):689-699.
PMID: 39271639
PMC: 11549138.
DOI: 10.1007/s13318-024-00916-1.
Physiologically Based Pharmacokinetic Model of OATP1B Substrates with a Nonlinear Mixed Effect Approach: Estimating Empirical In Vitro-to-In Vivo Scaling Factors.
Li R, Kimoto E, Bi Y, Tess D, Varma M
Clin Pharmacokinet. 2024; 63(8):1177-1189.
PMID: 39158814
DOI: 10.1007/s40262-024-01408-w.
The use of quantitative clinical pharmacology approaches to support moxidectin dosing recommendations in lactation.
Wood N, Smith D, Kinrade S, Sullivan M, Rayner C, Wesche D
PLoS Negl Trop Dis. 2024; 18(8):e0012351.
PMID: 39102440
PMC: 11326704.
DOI: 10.1371/journal.pntd.0012351.
No dose adjustment of metformin or substrates of organic cation transporters (OCT)1 and OCT2 and multidrug and toxin extrusion protein (MATE)1/2K with fostemsavir coadministration based on modeling approaches.
Nguyen D, Miao X, Taskar K, Magee M, Gorycki P, Moore K
Pharmacol Res Perspect. 2024; 12(4):e1238.
PMID: 38988092
PMC: 11237172.
DOI: 10.1002/prp2.1238.